Reduced-dose of bivalirudin (without the post-procedure infusion) in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.

Autor: Wang Q; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Liu Y; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Yang L; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Zhou T; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Zhang Q; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Zhang Z; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Sun D; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China., Wang X; State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, 83 Wenhua Road, Shenyang, Liaoning, 110016, China. wxiaozeng@163.com.

Publikováno v: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2024 Dec 19; Vol. 24 (1), pp. 713. Date of Electronic Publication: 2024 Dec 19.

Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology.

Autor: Xiao H; The Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, PR China., Meng X; Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China. Electronic address: mengxr@cdutcm.edu.cn., Songtao Li; Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China., Li Z; The Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, PR China., Fang S; The Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, PR China., Wang Y; The Core Facilities of Modern Pharmaceuticals, School of Pharmaceutical Sciences, Capital Medical University, Beijing, 100069, PR China., Li J; The Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, PR China., Tang J; Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, PR China. Electronic address: tangjy@cdutcm.edu.cn., Ma L; The Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, 100069, PR China. Electronic address: marytcm@ccmu.edu.cn.

Publikováno v: Biomaterials [Biomaterials] 2024 Dec; Vol. 311, pp. 122670. Date of Electronic Publication: 2024 Jun 17.

Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Recombinant Neorudin, a New Anticoagulant Drug in Patients With Acute Coronary Syndrome.

Autor: Liu YB; Beijing Institute of Radiation Medicine, Beijing, China.; Institute of Zhejiang University, Quzhou, Zhejiang, China., Liang Y; Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China., Liu HC; Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China., Feng GX; Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China., Zhou XC; Beijing Institute of Radiation Medicine, Beijing, China.; Institute of Zhejiang University, Quzhou, Zhejiang, China., Zhang L; Beijing Institute of Radiation Medicine, Beijing, China.; The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Zhejiang, China., Zhang XL; Institute of Zhejiang University, Quzhou, Zhejiang, China., Li Q; Beijing Institute of Radiation Medicine, Beijing, China., Ren BY; Beijing Institute of Radiation Medicine, Beijing, China., Xia X; Beijing SH Biotechnology Co., Ltd., Beijing, China., Zhu J; Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China., Wu CT; Beijing Institute of Radiation Medicine, Beijing, China., Jin JD; Beijing Institute of Radiation Medicine, Beijing, China.

Publikováno v: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Nov; Vol. 13 (11), pp. 1189-1197. Date of Electronic Publication: 2024 Oct 09.

Bivalirudin for unsalvageable venous congestion or obstruction in head and neck free flap reconstruction.

Autor: Harris MK; Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Dang S; Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Smith JD; Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Chinn S; Department of Otolaryngology - Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI, USA., Sridharan SS; Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Contrera KJ; Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Spector ME; Department of Otolaryngology - Head and Neck Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address: spectorme@upmc.edu.

Publikováno v: Oral oncology [Oral Oncol] 2024 Dec; Vol. 159, pp. 107076. Date of Electronic Publication: 2024 Oct 14.

Bivalirudin vs Heparin Anticoagulation in STEMI: Confirmation of the BRIGHT-4 Results.

Autor: Stone GW; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: gregg.stone@mountsinai.org., Valgimigli M; Bern University Hospital, University of Bern, Bern, Switzerland., Erlinge D; Lund University, Lund, Sweden., Han Y; General Hospital of Northern Theater Command, Shenyang, China., Steg PG; Université Paris-Cité, FACT (French Alliance for Cardiovascular Trials), INSERM U-1148, AP-HP, Hôpital Bichat, Paris, France; Imperial College, Royal Brompton Hospital, London, United Kingdom., Stables RH; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom; University of Liverpool, Liverpool, United Kingdom., Frigoli E; Bern University Hospital, University of Bern, Bern, Switzerland., James SK; Uppsala University, Uppsala, Sweden., Li Y; General Hospital of Northern Theater Command, Shenyang, China., Goldstein P; Lille University Hospital, Lille, France., Mehran R; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Mehdipoor G; Division of Nuclear Medicine, Department of Radiology, Montefiore Medical Center, Bronx, New York, USA., Crowley A; Genesis Research, Hoboken, New Jersey, USA., Chen S; Weill Cornell Medical Center, New York-Presbyterian Hospital, New York, New York, USA., Redfors B; Cardiovascular Research Foundation, New York, New York, USA., Snyder C; Cardiovascular Research Foundation, New York, New York, USA., Zhou Z; Cardiovascular Research Foundation, New York, New York, USA., Bikdeli B; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; YNHH/ Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, USA.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 Oct 15; Vol. 84 (16), pp. 1512-1524.